# Phase IV-Cervical Dystonia-INTEREST IN CD2

> **NCT01753349** · — · COMPLETED · sponsor: **Ipsen** · enrollment: 1050 (actual)

## Conditions studied

- Cervical Dystonia

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT01753349
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2017-09
- **Final completion:** 2017-09-25
- **Target enrollment:** 1050 (ACTUAL)
- **Last updated:** 2020-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01753349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01753349, "Phase IV-Cervical Dystonia-INTEREST IN CD2". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01753349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*